These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35910533)

  • 1. Why Cell-Free DNA Can Be a "Game Changer" for Lung Allograft Monitoring for Rejection and Infection.
    Rosenheck JP; Keller BC; Fehringer G; Demko ZP; Bohrade SM; Ross DJ
    Curr Pulmonol Rep; 2022; 11(3):75-85. PubMed ID: 35910533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free DNA in lung transplantation: research tool or clinical workhorse?
    Keller M; Agbor-Enoh S
    Curr Opin Organ Transplant; 2022 Jun; 27(3):177-183. PubMed ID: 35649108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant.
    Rosenheck JP; Ross DJ; Botros M; Wong A; Sternberg J; Chen YA; Liang N; Baer A; Ahmed E; Swenerton R; Zimmermann BG; Fehringer G; Demko ZP; Olymbios M; Billings PR; Keller BC
    Transplant Direct; 2022 Apr; 8(4):e1317. PubMed ID: 35372675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.
    Keller M; Sun J; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Heart Lung Transplant; 2022 Apr; 41(4):458-466. PubMed ID: 35063338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition of Renal Patients Using AlloSure Into Community Kidney Care (TRACK): Protocol for Long-Term Allograft Surveillance in Renal Transplant Recipients.
    Dale BL; Bose S; Kuo S; Burns A; Daou P; Short J; Miles J
    JMIR Res Protoc; 2021 Mar; 10(3):e25941. PubMed ID: 33720033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-Derived Cell-Free DNA for Acute Rejection Monitoring in Heart and Lung Transplantation.
    Keller M; Agbor-Enoh S
    Curr Transplant Rep; 2021; 8(4):351-358. PubMed ID: 34754720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Variation of Donor-Derived Cell-Free DNA in Stable Lung Transplant Recipients.
    Keller M; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Appl Lab Med; 2022 Jun; 7(4):901-909. PubMed ID: 35024828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation.
    Khush KK; De Vlaminck I; Luikart H; Ross DJ; Nicolls MR
    ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33532456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients.
    Ju C; Xu X; Zhang J; Chen A; Lian Q; Liu F; Liu H; Cai Y; Zou Y; Yang Y; Zhou Y; He J
    BMC Pulm Med; 2023 Jan; 23(1):37. PubMed ID: 36703125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Donor-derived Cell-free DNA Levels Are Increased During Acute Cellular Rejection After Lung Transplant: Pilot Data.
    Sayah D; Weigt SS; Ramsey A; Ardehali A; Golden J; Ross DJ
    Transplant Direct; 2020 Oct; 6(10):e608. PubMed ID: 33062841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR.
    Sigdel TK; Archila FA; Constantin T; Prins SA; Liberto J; Damm I; Towfighi P; Navarro S; Kirkizlar E; Demko ZP; Ryan A; Sigurjonsson S; Sarwal RD; Hseish SC; Chan-On C; Zimmermann B; Billings PR; Moshkevich S; Sarwal MM
    J Clin Med; 2018 Dec; 8(1):. PubMed ID: 30583588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study.
    Osmanodja B; Akifova A; Oellerich M; Beck J; Bornemann-Kolatzki K; Schütz E; Budde K
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.
    Bu L; Gupta G; Pai A; Anand S; Stites E; Moinuddin I; Bowers V; Jain P; Axelrod DA; Weir MR; Wolf-Doty TK; Zeng J; Tian W; Qu K; Woodward R; Dholakia S; De Golovine A; Bromberg JS; Murad H; Alhamad T
    Kidney Int; 2022 Apr; 101(4):793-803. PubMed ID: 34953773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
    Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status.
    Thongprayoon C; Vaitla P; Craici IM; Leeaphorn N; Hansrivijit P; Salim SA; Bathini T; Rivera FHC; Cheungpasitporn W
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32423115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions.
    Kataria A; Kumar D; Gupta G
    Transplantation; 2021 Jun; 105(6):1203-1211. PubMed ID: 33534526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients.
    Levitsky J; Kandpal M; Guo K; Kleiboeker S; Sinha R; Abecassis M
    Am J Transplant; 2022 Feb; 22(2):532-540. PubMed ID: 34510731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration.
    Lakhani L; Alasfar S; Bhalla A; Aala A; Rosenberg A; Ostrander D; Schollenberger MD; Brennan DC; Lipson EJ
    Transplant Direct; 2021 Feb; 7(2):e656. PubMed ID: 33490381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologist interrater reliability and clinical implications of elevated donor-derived cell-free DNA beyond heart transplant rejection, on behalf of the GRAfT investigators.
    Mehta A; Goldberg J; Bagchi P; Marboe C; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Cochrane A; Tchoukina IF; Kong H; Lohmar BJ; Mcnair E; Valantine HA; Agbor-Enoh S; Berry GJ; Shah P
    J Heart Lung Transplant; 2024 Oct; ():. PubMed ID: 39424014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.